Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

References for PMC Articles for PubMed (Select 9835513)

1.

Simplification of drug dosage calculation by application of the surface area principle.

CRAWFORD JD, TERRY ME, ROURKE GM.

Pediatrics. 1950 May;5(5):783-90. No abstract available.

PMID:
15417279
2.

Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine.

Yuen GJ, Morris DM, Mydlow PK, Haidar S, Hall ST, Hussey EK.

J Clin Pharmacol. 1995 Dec;35(12):1174-80. Erratum in: J Clin Pharmacol 1996 Apr;36(4):373.

PMID:
8750368
3.

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.

Heald AE, Hsyu PH, Yuen GJ, Robinson P, Mydlow P, Bartlett JA.

Antimicrob Agents Chemother. 1996 Jun;40(6):1514-9.

4.

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group.

Lewis LL, Venzon D, Church J, Farley M, Wheeler S, Keller A, Rubin M, Yuen G, Mueller B, Sloas M, Wood L, Balis F, Shearer GM, Brouwers P, Goldsmith J, Pizzo PA.

J Infect Dis. 1996 Jul;174(1):16-25.

5.

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.

Moore KH, Yuen GJ, Raasch RH, Eron JJ, Martin D, Mydlow PK, Hussey EK.

Clin Pharmacol Ther. 1996 May;59(5):550-8.

PMID:
8646826
6.

Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates.

Blaney SM, Daniel MJ, Harker AJ, Godwin K, Balis FM.

Antimicrob Agents Chemother. 1995 Dec;39(12):2779-82.

7.

High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.

Harker AJ, Evans GL, Hawley AE, Morris DM.

J Chromatogr B Biomed Appl. 1994 Jul 1;657(1):227-32.

PMID:
7952073
8.

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.

Pluda JM, Cooley TP, Montaner JS, Shay LE, Reinhalter NE, Warthan SN, Ruedy J, Hirst HM, Vicary CA, Quinn JB, et al.

J Infect Dis. 1995 Jun;171(6):1438-47.

PMID:
7769277
9.

Phase I evaluation of zalcitabine administered to human immunodeficiency virus-infected children.

Chadwick EG, Nazareno LA, Nieuwenhuis TJ, Massarella JW, de Dennis SR, Williams K, Yogev R.

J Infect Dis. 1995 Dec;172(6):1475-9.

PMID:
7594705
10.

Limited sampling model for vinblastine pharmacokinetics.

Ratain MJ, Vogelzang NJ.

Cancer Treat Rep. 1987 Oct;71(10):935-9.

PMID:
3652057
11.

Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.

Collins JM, Klecker RW Jr, Kelley JA, Roth JS, McCully CL, Balis FM, Poplack DG.

J Pharmacol Exp Ther. 1988 May;245(2):466-70.

PMID:
3367302
13.

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

Balis FM, Pizzo PA, Eddy J, Wilfert C, McKinney R, Scott G, Murphy RF, Jarosinski PF, Falloon J, Poplack DG.

J Pediatr. 1989 May;114(5):880-4.

PMID:
2715903
14.

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.

Pizzo PA, Butler K, Balis F, Brouwers E, Hawkins M, Eddy J, Einloth M, Falloon J, Husson R, Jarosinski P, et al.

J Pediatr. 1990 Nov;117(5):799-808.

PMID:
2172501
15.

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog.

Soudeyns H, Yao XI, Gao Q, Belleau B, Kraus JL, Nguyen-Ba N, Spira B, Wainberg MA.

Antimicrob Agents Chemother. 1991 Jul;35(7):1386-90.

16.

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

Balis FM, Pizzo PA, Butler KM, Hawkins ME, Brouwers P, Husson RN, Jacobsen F, Blaney SM, Gress J, Jarosinski P, et al.

J Infect Dis. 1992 Jan;165(1):99-104.

PMID:
1727902
17.

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma.

Hart GJ, Orr DC, Penn CR, Figueiredo HT, Gray NM, Boehme RE, Cameron JM.

Antimicrob Agents Chemother. 1992 Aug;36(8):1688-94.

18.

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.

Coates JA, Cammack N, Jenkinson HJ, Jowett AJ, Jowett MI, Pearson BA, Penn CR, Rouse PL, Viner KC, Cameron JM.

Antimicrob Agents Chemother. 1992 Apr;36(4):733-9.

19.

Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells.

Sommadossi JP, Schinazi RF, Chu CK, Xie MY.

Biochem Pharmacol. 1992 Nov 17;44(10):1921-5.

PMID:
1333199
20.

Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine.

Cammack N, Rouse P, Marr CL, Reid PJ, Boehme RE, Coates JA, Penn CR, Cameron JM.

Biochem Pharmacol. 1992 May 28;43(10):2059-64.

PMID:
1318048
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk